Neuroproteção no acidente vascular celebral: opinião nacional

Freitas, Gabriel R. de; Noujaim, Jorge El Kadum; Haussen, Sérgio R; Yamamoto, Fábio I; Novak, Edson M; Gagliardi, Rubens J.
Arq. neuropsiquiatr ; 63(3B): 889-891, set. 2005. tab
Artigo em Português | LILACS | ID: lil-445123

Documentos relacionados

  1. [Neuroprotective agents in stroke: national opinion].
  2. Best practices in phase III clinical trials on DMTs for multiple sclerosis: a systematic analysis and appraisal of published trials.
  3. The effects of citicoline on acute ischemic stroke: a review.
  4. Premiers résultats des études vaccinales de phase 3: le tournant ?
  5. Controlled Human Infection Models To Accelerate Vaccine Development.
  6. The evolving landscape of pulmonary arterial hypertension clinical trials.
  7. Challenges in acute ischemic stroke clinical trials.
  8. C3-targeted therapy in periodontal disease: moving closer to the clinic.
  9. Emerging drugs for the treatment of moderately to severely active ulcerative colitis: review of phase II and III clinical trials.
  10. The fragility of phase 3 trials supporting FDA-approved anticancer medicines: a retrospective analysis.